Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06YGT
|
|||
| Former ID |
DNC003123
|
|||
| Drug Name |
N-Tridecanoic Acid
|
|||
| Synonyms |
TRIDECANOIC ACID; 638-53-9; n-Tridecanoic acid; Tridecylic acid; n-Tridecoic acid; NSC 25955; UNII-19936LIY2V; EINECS 211-341-1; NSC 69131; BRN 0508317; AI3-04166; CHEBI:45919; SZHOJFHSIKHZHA-UHFFFAOYSA-N; 19936LIY2V; 68002-90-4; C13:0; n-Tridecanoic acid, 97%; Tridecanoic acid, > Tridecanoic acid anion; WLN: QV12; Fatty acids, C10-16; C10-16 fatty acids; Tridecylate; Carboxylic acids, C10-16; tridecoic acid; n-Tridecanoate; n-Tridecoate; (C10-C16) Carboxylic acid; (C10-C16)Alkylcarboxylic acid; EINECS 268-105-6
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C13H26O2
|
|||
| Canonical SMILES |
CCCCCCCCCCCCC(=O)O
|
|||
| InChI |
1S/C13H26O2/c1-2-3-4-5-6-7-8-9-10-11-12-13(14)15/h2-12H2,1H3,(H,14,15)
|
|||
| InChIKey |
SZHOJFHSIKHZHA-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 638-53-9
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
86946, 113147, 584282, 821884, 831051, 832898, 833043, 838003, 838009, 3134737, 5584561, 7849667, 7890723, 8159381, 10531417, 11450742, 14822523, 24889591, 24899890, 26697110, 29280743, 46505422, 48414876, 49834367, 50058067, 56371581, 57327673, 76186899, 81064616, 85090066, 85247471, 87576366, 88823031, 92297958, 96023554, 103329670, 104329247, 118316866, 124954908, 125355282, 126497181, 126523672, 126546523, 126674674, 128396617, 129310330, 129767658, 129903580, 131322205, 134412488
|
|||
| ChEBI ID |
CHEBI:45919
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Group IIA phospholipase A2 (GIIA sPLA2) | Target Info | Inhibitor | [1] |
| Phospholipase A2 (PLA2G1B) | Target Info | Inhibitor | [1] | |
| BioCyc | Phospholipases | |||
| KEGG Pathway | Glycerophospholipid metabolism | |||
| Ether lipid metabolism | ||||
| Arachidonic acid metabolism | ||||
| Linoleic acid metabolism | ||||
| alpha-Linolenic acid metabolism | ||||
| Metabolic pathways | ||||
| Ras signaling pathway | ||||
| Vascular smooth muscle contraction | ||||
| Pancreatic secretion | ||||
| Fat digestion and absorption | ||||
| Pathway Interaction Database | Fc-epsilon receptor I signaling in mast cells | |||
| Glypican 1 network | ||||
| Reactome | Acyl chain remodelling of PC | |||
| Acyl chain remodelling of PE | ||||
| Acyl chain remodelling of PI | ||||
| WikiPathways | Glycerophospholipid biosynthesis | |||
| Cardiac Hypertrophic Response | ||||
| Glycerophospholipid Biosynthetic Pathway | ||||
| Spinal Cord Injury | ||||
| Eicosanoid Synthesis | ||||
| MicroRNAs in cardiomyocyte hypertrophy | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.